ABL Diagnostics Successfully Verifies DeepChek® Assays & Software on Illumina’s MiSeq™ i100 & MiSeqDx Platforms
WOIPPY, FRANCE, May 21, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is proud to announce the successful verification of its DeepChek® Assays and Software …